|
Neonatal Intensive Care Drug Manual
|
| bet | 19/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Practice points
|
|
References
|
Palasanthiran P, Starr M, Jones C, Giles M. Management of Perinatal Infections, Australasian Society for Infectious Diseases (ASID), 2014
Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230-8.
Englund JA, Fletcher CV, Balfour HH. Acyclovir therapy in neonates. The Journal of pediatrics. 1991;119(1):129-35.
Sampson MR, Bloom BT, Lenfestey RW, Harper B, Kashuba AD, Anand R, Benjamin Jr DK, Capparelli E, Cohen-Wolkowiez M, Smith PB. Population pharmacokinetics of intravenous acyclovir in preterm and term infants. The Pediatric infectious disease journal. 2014;33(1):42.
Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, Palmer A, Sánchez PJ, Jacobs RF, Bradley JS, Robinson JL. Oral acyclovir suppression and neurodevelopment after neonatal herpes. New England Journal of Medicine. 2011;365(14):1284-92.
Australian Injectable Drugs Handbook, 6th Edition, 2016
The Paediatric Injectable Medicines Handbook, The Children's Hospital at Westmead, accessed 22/11/2016
Micromedex online. Accessed on 22/11/2016.
|
Original version Date: 29/12/2016
|
Author: NMF Consensus Group
|
Current Version number: 2.0
|
Current Version Date: 16/11/2020
|
Risk Rating: Low
|
Due for Review: 16/11/2025
|
Approval by: DTC
|
Approval Date:April 2020
|
|
| |
